- Home
- NUVB vs GRNT Comparison
NUVB vs GRNT Comparison
Compare NUVB & GRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- GRNT
- Stock Information
- Founded
- NUVB 2018
- GRNT 2013
- Country
- NUVB United States
- GRNT United States
- Employees
- NUVB N/A
- GRNT N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- GRNT Blank Checks
- Sector
- NUVB Health Care
- GRNT Finance
- Exchange
- NUVB Nasdaq
- GRNT Nasdaq
- Market Cap
- NUVB 679.9M
- GRNT 727.7M
- IPO Year
- NUVB N/A
- GRNT N/A
- Fundamental
- Price
- NUVB $2.12
- GRNT $5.62
- Analyst Decision
- NUVB Strong Buy
- GRNT Hold
- Analyst Count
- NUVB 5
- GRNT 3
- Target Price
- NUVB $8.20
- GRNT $7.33
- AVG Volume (30 Days)
- NUVB 4.2M
- GRNT 327.2K
- Earning Date
- NUVB 05-07-2025
- GRNT 05-08-2025
- Dividend Yield
- NUVB N/A
- GRNT 7.83%
- EPS Growth
- NUVB N/A
- GRNT N/A
- EPS
- NUVB N/A
- GRNT 0.09
- Revenue
- NUVB $10,957,000.00
- GRNT $390,665,000.00
- Revenue This Year
- NUVB $95.27
- GRNT $27.73
- Revenue Next Year
- NUVB $345.44
- GRNT $7.82
- P/E Ratio
- NUVB N/A
- GRNT $62.37
- Revenue Growth
- NUVB N/A
- GRNT 6.26
- 52 Week Low
- NUVB $1.54
- GRNT $4.52
- 52 Week High
- NUVB $3.97
- GRNT $7.10
- Technical
- Relative Strength Index (RSI)
- NUVB 47.71
- GRNT 55.86
- Support Level
- NUVB $2.14
- GRNT $5.41
- Resistance Level
- NUVB $2.42
- GRNT $5.88
- Average True Range (ATR)
- NUVB 0.16
- GRNT 0.14
- MACD
- NUVB -0.01
- GRNT 0.03
- Stochastic Oscillator
- NUVB 27.71
- GRNT 44.79
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About GRNT Granite Ridge Resources Inc.
Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.